Announcements
HHS enlists AktiVax to develop improved auto-injector for nerve agent antidotes
One of the drugs stockpiled by the U.S. government to save lives from chemical nerve agents needs a new auto-injector so the drug can be used quickly and safely without specialized training if an attack occurs in the United States.
Philadelphia company selected to accelerate innovation for U.S. health security, daily medical care
University City Science Center of Philadelphia has been selected as one of eight accelerators in the nation by the U.S. Department of Health and Human Services (HHS) to drive innovation in lifesaving medical technologies that solve challenging problems spanning modern health security threats and daily medical care.
Houston company selected to accelerate innovation for U.S. health security, daily medical care
Texas Medical Center Innovation Institute of Houston has been selected as one of eight accelerators in the nation by the U.S. Department of Health and Human Services (HHS) to drive innovation in lifesaving medical technologies that solve challenging problems spanning modern health security threats and daily medical care.
